Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquitin-like protein 4B (UBL4B) is a testis-specific autosomal retrogene that emerged from the X-linked housekeeping gene UBL4A in mammals through retroposition[3][1]. UBL4B is expressed specifically in post-meiotic male germ cells (especially during late spermiogenesis), and encodes a cytoplasmic protein with a conserved ubiquitin-like domain, similar to other ubiquitin-related modifiers[3]. While its ancestral paralog UBL4A is broadly expressed and involved in protein metabolism and immune responses, the functional significance of UBL4B appears specialized for male germ cell maturation and is dispensable for overall spermatogenesis or fertility, as knockout mice show no major reproductive or developmental defects[1][3]. There is currently no evidence that UBL4B plays a direct role as a therapeutic drug target, nor does it have established links to disease, pathogenic mechanisms, or known drug interactions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin-like protein 4B (UBL4B).